Unknown PHASE3 INTERVENTIONAL 2-arm NCT01867775

Mirtazapine for Sleep Disorders in Alzheimer's Disease

Mirtazapine for the Treatment of Sleep Disorders in Alzheimer's Disease: a Randomized, Double-blind, Placebo-controlled Study

Sponsor: Brasilia University Hospital

Conditions Alzheimer's Disease Sleep Disorders

Interventions Mirtazapine

Updated 6 times since 2017 Last updated: Jun 3, 2013 Started: May 31, 2012 Primary completion: Dec 31, 2013 Completion: May 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01867775, this PHASE3 trial focuses on Alzheimer's Disease and Sleep Disorders and remains ongoing. Sponsored by Brasilia University Hospital, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE3
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Brasilia University Hospital

Data source: Brasilia University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brasília, Brazil